The NTR-CL-E1 could generate ROS in MDA-MB231 triple-negative breast cancer cells expressing NTR and inducing cancer cell death (IC50 = 1.9 ± 0.7 μM) based on the NTR activity (Figure 4D–F). The gene discussed is NTSR1; the disease is triple-negative breast carcinoma.